Yakult

News Releases

LivTech and Yakult Honsha Enter into Option Agreement for LIV-2008,LivTech’s Anti-Cancer Monoclonal Antibodies Program

Nov 2011

Back

Fiscal year

More
トップへ戻る

Our website uses cookies to provide users with a better service. Please click on “Accept” if you agree to our use of cookies. Click on “See details” for information on cookies and their setting.

Accept
See details